Stay updated on Volitinib for Primary CNS Tumors Clinical Trial
Sign up to get notified when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.

Latest updates to the Volitinib for Primary CNS Tumors Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.8.0 instead of v3.7.2. The study page remains unavailable and displays a 403 Forbidden message.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA sitewide NIH notice was added about the transition from “Artificial Intelligence” to “Super Intelligence,” and the displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check47 days agoChange DetectedThis change removes links and files for critical study documents from the record, including consent forms and the protocol; the study page will have fewer references to its foundational materials and procedures.SummaryDifference23%

- Check54 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous v3.6.6, signaling a routine platform update rather than a modification to the study details.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5 on the page, indicating a new build of the site's framework or styling. This update appears to be a backend/software change with no visible changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Volitinib for Primary CNS Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.